Standardization of the Italian ALS-CBS™ Caregiver Behavioral Questionnaire
暂无分享,去创建一个
A. Compare | I. Appollonio | S. Messina | N. Ticozzi | F. Verde | V. Silani | Jennifer Murphy | S. Woolley | L. Carelli | F. Solca | B. Poletti | A. Brugnera | V. Sansone | L. Tremolizzo | C. Morelli | A. Doretti | C. Lunetta | Antonino La Tona | F. Cerri | E. Aiello | A. Lizio | L. Greco | Silvia Torre | E. Colombo | D. Pain | J. Casiraghi | Alice Radici | Eleonora Colombo
[1] R. Ferrucci,et al. Diagnostic properties of the Italian ECAS Carer Interview (ECAS-CI) , 2022, Neurological Sciences.
[2] Stephen A. Goutman,et al. Amyotrophic lateral sclerosis , 2022, The Lancet.
[3] N. Bolognini,et al. Psychometrics, diagnostics and usability of Italian tools assessing behavioural and functional outcomes in neurological, geriatric and psychiatric disorders: a systematic review , 2022, Neurological Sciences.
[4] S. Abrahams,et al. International evaluation of current practices in cognitive assessment for motor neurone disease , 2022, British Journal of Neuroscience Nursing.
[5] M. Filippi,et al. A preliminary comparison between ECAS and ALS-CBS in classifying cognitive–behavioural phenotypes in a cohort of non-demented amyotrophic lateral sclerosis patients , 2021, Journal of Neurology.
[6] A. Chiò,et al. Italian adaptation of the Beaumont Behavioral Inventory (BBI): psychometric properties and clinical usability , 2021, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[7] Monica Consonni,et al. Cognitive and behavioural impairment in amyotrophic lateral sclerosis: A landmark of the disease? A mini review of longitudinal studies , 2021, Neuroscience Letters.
[8] S. Chandran,et al. A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis , 2020, Journal of Neurology.
[9] M. V. van Es,et al. An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice , 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[10] Colin J. Mahoney,et al. The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis , 2020, Expert review of neurotherapeutics.
[11] M. Filippi,et al. ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability , 2019, Neurological Sciences.
[12] L. Goldstein,et al. Screening for cognitive and behavioral change in amyotrophic lateral sclerosis/motor neuron disease: a systematic review of validated screening methods , 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[13] R. Goetz,et al. Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients , 2018, Behavioural neurology.
[14] Theodoros A. Kyriazos,et al. Applied Psychometrics: Sample Size and Sample Power Considerations in Factor Analysis (EFA, CFA) and SEM in General , 2018 .
[15] T. Hortobágyi,et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria , 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[16] S. Cuoco,et al. Assessment of apathy independent of physical disability: validation of the Dimensional Apathy Scale in Italian healthy sample , 2017, Neurological Sciences.
[17] F. Madotto,et al. The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS) , 2016, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[18] Gokmen Zararsiz,et al. easyROC: An Interactive Web-tool for ROC Curve Analysis Using R Language Environment , 2016, R J..
[19] Hae-Young Kim. Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis , 2013, Restorative dentistry & endodontics.
[20] A. Thompson,et al. What sample sizes for reliability and validity studies in neurology? , 2012, Journal of Neurology.
[21] Nick C Fox,et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.
[22] B. Miller,et al. Classification of primary progressive aphasia and its variants , 2011, Neurology.
[23] M. York,et al. Detecting frontotemporal dysfunction in ALS: Utility of the ALS Cognitive Behavioral Screen (ALS-CBS™) , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[24] P. Bossuyt. Clinical validity: Defining biomarker performance , 2010, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[25] A. Kertesz,et al. The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer's disease , 2007, Neurological Sciences.
[26] M. Swash,et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[27] J. Cedarbaum,et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function , 1999, Journal of the Neurological Sciences.
[28] 福田 博一. State-Trait Anxiety Inventoryによるペインクリニック外来患者の不安の評価 , 1994 .
[29] A. Beck,et al. An inventory for measuring depression. , 1961, Archives of general psychiatry.